SOHO State of the Art Updates and Next Questions: Management of Asparaginase Toxicity in Adolescents and Young Adults with Acute Lymphoblastic Leukemia
Author:
Funder
Kræftens Bekæmpelse
Børnecancerfonden
Publisher
Elsevier BV
Subject
Cancer Research,Oncology,Hematology
Reference138 articles.
1. Pharmacokinetics-based integration of multiple doses of intravenous pegaspargase in a pediatric regimen for adults with newly diagnosed acute lymphoblastic leukemia;Douer;J Clin Oncol,2014
2. Results of NOPHO ALL2008 treatment for patients aged 1-45 years with acute lymphoblastic leukemia;Toft;Leukemia,2018
3. A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403;Stock;Blood,2019
4. Toxicity profile and treatment delays in NOPHO ALL2008-comparing adults and children with Philadelphia chromosome-negative acute lymphoblastic leukemia;Toft;Eur J Haematol,2016
5. Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open-Cancer Horizons roundtable discussion;Burke;ESMO Open,2020
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Adolescents and young adults (AYAs) vs pediatric patients: survival, risks, and barriers to enrollment;Hematology;2023-12-08
2. A Review of L-Asparaginase Hypersensitivity in Paediatric Acute Lymphoblastic Leukaemia Patients with Regard to the Measurement of Anti-Asparaginase Antibodies and Their Genetic Predisposition;Malaysian Journal of Medical Sciences;2023-10-30
3. Lack of benefit from premedication for pegylated asparaginase during pediatric acute lymphoblastic leukemia/lymphoma therapy: A side‐by‐side comparison;Pediatric Blood & Cancer;2023-10-19
4. The efficacy and toxicity of L-asparaginase in the treatment of acute lymphoblastic leukemia in children;Pediatric Hematology/Oncology and Immunopathology;2023-10-03
5. Children's Oncology Group 2023 blueprint for research: Adolescent and young adult oncology;Pediatric Blood & Cancer;2023-07-13
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3